title: Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.
abstract: Gene augmentation therapy as a strategy to treat alpha-1 antitrypsin (AAT) deficiency has reached phase 2 clinical testing in humans. Sustained serum levels of AAT have been observed beyond one year after intramuscular administration of a recombinant adeno-associated virus (rAAV) vector expressing the AAT gene. In this study, sequential muscle biopsies obtained at 3 and 12 months after vector injection were examined for the presence of rAAV vector genomes. Each biopsy sample contained readily detectable vector DNA, the majority of which existed as double-stranded supercoiled and open circular episomes. Episomes persisted through 12 months, although at slightly lower levels than observed at 3 months. There was a clear dose response when comparing the low- and mid-vector-dose groups to the high-dose group. The highest absolute copy numbers were found in a high-dose subject, and serum AAT levels at 12 months confirmed that the high-dose group also had the highest sustained serum AAT levels. Sequence analysis revealed that the vast majority of episomes contained double-D inverted terminal repeats ranging from fully intact to severely deleted. Molecular clones of vector genomes derived directly from the biopsies were transcriptionally active, potentially identifying them as the source of serum AAT in the trial subjects.
authors.affiliation: 1 The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Schnepp
authors.affiliation: 2 Applied Genetic Technologies Corporation, Alachua, Florida.
authors.forename: Jeffrey D
authors.initials: JD
authors.lastname: Chulay
authors.affiliation: 2 Applied Genetic Technologies Corporation, Alachua, Florida.
authors.forename: Guo-Jie
authors.initials: GJ
authors.lastname: Ye
authors.affiliation: 3 University of Massachusetts Medical School , Worcester, Massachusetts.
authors.forename: Terence R
authors.initials: TR
authors.lastname: Flotte
authors.affiliation: 4 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Trapnell
authors.affiliation: 1 The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
authors.forename: Philip R
authors.initials: PR
authors.lastname: Johnson
mesh_terms: D001483:Base Sequence / Q000235:genetics; D000229:Dependovirus / Q000235:genetics* / Q000378:metabolism; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics; D016678:Genome; D006801:Humans; D018482:Muscle, Skeletal / Q000378:metabolism*; D010957:Plasmids / Q000235:genetics* / Q000378:metabolism